IVVD Form 144 Filed for 39,601 Shares via Morgan Stanley on Nasdaq

Rhea-AI Filing Summary

Form 144 notice for Invivyd, Inc. (IVVD) indicates a proposed sale of 39,601 shares of common stock on or about 08/18/2025 through Morgan Stanley Smith Barney LLC on the Nasdaq, with an aggregate market value reported as $28,001.87. The shares were acquired upon vesting of restricted stock units under the issuer's 2021 Equity Incentive Plan and were recorded as acquired and paid on 08/15/2025. The filer reports no securities sold in the past three months. Several identifying fields in the filing (filer CIK, contact details, issuer name and person for whose account the sale is to be made) are not populated in the provided content.

Positive

• Transaction details provided: class, broker, quantity, aggregate market value, approximate sale date, and exchange are reported
• Securities acquisition fully documented: 99,000 units acquired via RSU vesting on 08/15/2025 with payment characterized as equity compensation
• No sales in prior three months: the filing states "Nothing to Report" for securities sold during the past 3 months

Negative

• Key identification fields missing: filer CIK, filer contact information, issuer name, and the person for whose account the sale is to be made are not populated in the provided content
• Limited traceability from excerpt: missing identifying and contact details restrict verification and follow-up based solely on this excerpt

Insights

Securities Analyst

TL;DR: Proposed sale of 39,601 shares via Morgan Stanley; shares stem from RSU vesting and have modest reported market value.

The filing documents a planned transaction of 39,601 common shares to be executed on or about 08/18/2025 on Nasdaq through Morgan Stanley Smith Barney LLC with an aggregate market value of $28,001.87. Acquisition records show the shares were received from the issuer on 08/15/2025 as vested restricted stock units under the 2021 Equity Incentive Plan and were paid for via equity compensation mechanisms on that same date. The filer indicates no sales in the prior three months. Key identification fields are blank in the supplied content, which limits confirmatory detail.

Compliance/Risk Analyst

TL;DR: Filing contains required transaction details but omits several filer and issuer identifiers, reducing traceability.

The form includes the necessary transaction tables describing class, broker, quantity, acquisition date, and payment nature and contains the filer’s attestation language regarding material nonpublic information and 10b5-1 plan notice. However, the provided content lacks explicit entries for filer CIK, submission contact information, issuer name, and the named person for whose account the sale will occur. Those omissions in the supplied text constrain regulatory traceability and reviewer verification based on this excerpt alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	39601	28001.87	120142811	08/18/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/15/2025	Common Stock acquired upon vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan	Issuer			99000	08/15/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the Form 144 for IVVD propose to sell?

The form proposes to sell 39,601 shares of common stock on or about 08/18/2025 via Morgan Stanley Smith Barney LLC on the Nasdaq.

What is the reported aggregate market value of the proposed sale?

The aggregate market value reported in the filing is $28,001.87.

How were the securities being sold acquired?

The securities were acquired on 08/15/2025 upon vesting of restricted stock units granted under the issuer's 2021 Equity Incentive Plan and payment is recorded as Equity Compensation.

Were any securities of the issuer sold by the filer in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Does the provided content include filer and issuer identification details?

No. The supplied excerpt does not populate the filer CIK, contact information, issuer name, or the named person for whose account the sale is to be made.